Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1983-11-14
1986-09-16
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514806, 530311, A61K 3724, C07K 726
Patent
active
046123024
ABSTRACT:
A method of increasing the clearance of particles from the blood stream of a vertebrate, which comprises administering to a vertebrate having a surplus of particles in the blood stream of the vertebrate an amount of a somatostatin analogue sufficient to increase phagocytosis in the vertebrate is disclosed along with a method treating vascular lesions or deterioration of biological membranes comprising the step of administering to a human or other mammal suspected of having one or more vascular lesions or of having deterioration of a biological membrane in the liver of said human or mammal an amount of a somatostatin analogue sufficient to reduce the number or severity of said lesions or to prevent further deterioration or reduce the extent of deterioration of said membrane.
REFERENCES:
patent: 4224199 (1980-09-01), Meyers et al.
patent: 4280953 (1981-07-01), Guillemin et al.
patent: 4310518 (1982-01-01), Freidinger et al.
patent: 4316890 (1982-02-01), Kamber et al.
patent: 4316891 (1982-02-01), Guillemin et al.
patent: 4328214 (1982-04-01), Rink et al.
patent: 4360516 (1982-11-01), Freidinger et al.
patent: 4366148 (1982-12-01), Szabo et al.
patent: 4369179 (1983-01-01), Rink et al.
Veber et al., Nature, 292, 55-58, (1981).
Kessler Horst
Szabo Sandor
Usadel Klaus W.
Brigham and Women's Hospital
Phillips Delbert R.
LandOfFree
Clinical use of somatostatin analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Clinical use of somatostatin analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Clinical use of somatostatin analogues will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1995759